• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与肝细胞癌预后及免疫浸润相关的新型上皮-间质转化基因特征

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.

作者信息

Kong Weihao, Mao Zhongxiang, Han Chen, Ding Zhenxing, Yuan Qianqian, Zhang Gaosong, Li Chong, Wu Xuesheng, Chen Jia, Guo Manyu, Hong Shaocheng, Yu Feng, Liu Rongqiang, Wang Xingyu, Zhang Jianlin

机构信息

Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Registration Review Department, Anhui Center for Drug Evaluation & Inspection, Hefei, China.

出版信息

Front Pharmacol. 2022 Apr 20;13:863750. doi: 10.3389/fphar.2022.863750. eCollection 2022.

DOI:10.3389/fphar.2022.863750
PMID:35517787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9065556/
Abstract

Although many genes related to epithelial-mesenchymal transition (EMT) have been explored in hepatocellular carcinoma (HCC), their prognostic significance still needs further analysis. Differentially expressed EMT-related genes were obtained through the integrated analysis of 4 Gene expression omnibus (GEO) datasets. The univariate Cox regression and Lasso Cox regression models are utilized to determine the EMT-related gene signature. Based on the results of multivariate Cox regression, a predictive nomogram is established. Time-dependent ROC curve and calibration curve are used to show the distinguishing ability and consistency of the nomogram. Finally, we explored the correlation between EMT risk score and immune immunity. We identified a nine EMT-related gene signature to predict the survival outcome of HCC patients. Based on the EMT risk score's median, HCC patients in each dataset were divided into high and low-risk groups. The survival outcomes of HCC patients in the high-risk group were significantly worse than those in the low-risk group. The prediction nomogram based on the EMT risk score has better distinguishing ability and consistency. High EMT risk score was related to immune infiltration. The nomogram based on the EMT risk score can reliably predict the survival outcome of HCC patients, thereby providing benefits for medical decisions.

摘要

尽管在肝细胞癌(HCC)中已经探索了许多与上皮-间质转化(EMT)相关的基因,但其预后意义仍需进一步分析。通过对4个基因表达综合数据库(GEO)数据集的综合分析,获得了差异表达的EMT相关基因。利用单变量Cox回归和Lasso Cox回归模型来确定EMT相关基因特征。基于多变量Cox回归结果,建立了预测列线图。采用时间依赖性ROC曲线和校准曲线来展示列线图的区分能力和一致性。最后,我们探讨了EMT风险评分与免疫的相关性。我们鉴定出一个由9个EMT相关基因组成的特征,用于预测HCC患者的生存结局。根据EMT风险评分的中位数,将每个数据集中的HCC患者分为高风险组和低风险组。高风险组HCC患者的生存结局明显比低风险组差。基于EMT风险评分的预测列线图具有更好的区分能力和一致性。高EMT风险评分与免疫浸润相关。基于EMT风险评分的列线图能够可靠地预测HCC患者的生存结局,从而为医疗决策提供帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/7238e0e84429/fphar-13-863750-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/d72a60b1ec14/fphar-13-863750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/32960486e219/fphar-13-863750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/90022185084e/fphar-13-863750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/609c5dbfabdd/fphar-13-863750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/406393b389a0/fphar-13-863750-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/e09421271c10/fphar-13-863750-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/3b308a17b2cd/fphar-13-863750-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/71c1dd7a9220/fphar-13-863750-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/b4472b7a0fb3/fphar-13-863750-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/9dbe66bce24c/fphar-13-863750-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/f7769250b9f6/fphar-13-863750-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/7238e0e84429/fphar-13-863750-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/d72a60b1ec14/fphar-13-863750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/32960486e219/fphar-13-863750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/90022185084e/fphar-13-863750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/609c5dbfabdd/fphar-13-863750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/406393b389a0/fphar-13-863750-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/e09421271c10/fphar-13-863750-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/3b308a17b2cd/fphar-13-863750-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/71c1dd7a9220/fphar-13-863750-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/b4472b7a0fb3/fphar-13-863750-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/9dbe66bce24c/fphar-13-863750-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/f7769250b9f6/fphar-13-863750-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db1/9065556/7238e0e84429/fphar-13-863750-g012.jpg

相似文献

1
A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.一种与肝细胞癌预后及免疫浸润相关的新型上皮-间质转化基因特征
Front Pharmacol. 2022 Apr 20;13:863750. doi: 10.3389/fphar.2022.863750. eCollection 2022.
2
Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.鉴定一种与上皮-间质转化相关的长链非编码RNA预后特征以确定肝细胞癌患者的预后和药物治疗
Front Med (Lausanne). 2022 May 24;9:850343. doi: 10.3389/fmed.2022.850343. eCollection 2022.
3
Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.一种用于肝细胞癌的稳健的上皮-间质转化(EMT)相关预后标志物的开发与验证
Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101587. doi: 10.1016/j.clinre.2020.101587. Epub 2021 Mar 1.
4
Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.上皮间质转化相关的肝细胞癌预后模型的建立和验证。
Aging (Albany NY). 2021 Apr 30;13(10):13822-13845. doi: 10.18632/aging.202976.
5
Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.基于铁死亡和 EMT 状态的肝细胞癌预后预测和免疫浸润分析。
Front Immunol. 2022 Dec 15;13:1076045. doi: 10.3389/fimmu.2022.1076045. eCollection 2022.
6
An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.一种预测肝细胞癌患者预后的上皮-间质转化相关5基因特征
Cancer Cell Int. 2021 Mar 12;21(1):166. doi: 10.1186/s12935-021-01864-5.
7
Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.线粒体相关转录组特征与肝细胞癌的预后、血管侵犯、肿瘤微环境和治疗反应相关。
Oxid Med Cell Longev. 2022 Apr 30;2022:1592905. doi: 10.1155/2022/1592905. eCollection 2022.
8
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.基于上皮-间质转化相关基因的新型肝细胞癌风险预测模型。
Bioengineered. 2020 Dec;11(1):1034-1046. doi: 10.1080/21655979.2020.1822715.
9
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.结直肠癌患者上皮-间质转化的基因组学与预后分析。
BMC Cancer. 2020 Nov 23;20(1):1135. doi: 10.1186/s12885-020-07615-5.
10
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.一种九基因特征的鉴定及预测胰腺癌总生存期的预后列线图的建立
Front Oncol. 2019 Sep 27;9:996. doi: 10.3389/fonc.2019.00996. eCollection 2019.

引用本文的文献

1
Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.循环肿瘤细胞参与微血管侵犯的形成,并影响肝细胞癌的临床结局。
Front Genet. 2023 Nov 2;14:1265866. doi: 10.3389/fgene.2023.1265866. eCollection 2023.
2
PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma.PIK3CD与乳腺癌的预后、上皮-间质转化及肿瘤免疫浸润相关。
Discov Oncol. 2023 Oct 20;14(1):187. doi: 10.1007/s12672-023-00805-0.
3
Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma.

本文引用的文献

1
IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma.IL-6 诱导的 cGGNBP2 编码一种蛋白,促进肝内胆管癌中的细胞生长和转移。
Hepatology. 2022 Jun;75(6):1402-1419. doi: 10.1002/hep.32232. Epub 2021 Dec 21.
2
Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.外泌体 S100A4 来源于高转移性肝癌细胞,通过激活 STAT3 促进转移。
Signal Transduct Target Ther. 2021 May 26;6(1):187. doi: 10.1038/s41392-021-00579-3.
3
Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy.
用于肝细胞癌预后预测的丙酸盐代谢相关基因特征的开发与验证
J Hepatocell Carcinoma. 2023 Oct 2;10:1673-1687. doi: 10.2147/JHC.S420614. eCollection 2023.
4
Genistein Restricts the Epithelial Mesenchymal Transformation (EMT) and Stemness of Hepatocellular Carcinoma via Upregulating miR-1275 to Inhibit the EIF5A2/PI3K/Akt Pathway.金雀异黄素通过上调miR-1275抑制EIF5A2/PI3K/Akt通路,从而限制肝细胞癌的上皮-间质转化(EMT)和干性。
Biology (Basel). 2022 Sep 22;11(10):1383. doi: 10.3390/biology11101383.
5
A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma.一种预测肝细胞癌预后的新型嘌呤与尿酸代谢特征
Front Genet. 2022 Jul 12;13:942267. doi: 10.3389/fgene.2022.942267. eCollection 2022.
开颅术后脑转移结局的多组学分析
Front Oncol. 2021 Apr 6;10:615472. doi: 10.3389/fonc.2020.615472. eCollection 2020.
4
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
5
Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma.将癌症相关成纤维细胞鉴定为肝细胞癌的新靶点。
Cell Biosci. 2020 Oct 31;10(1):127. doi: 10.1186/s13578-020-00488-y.
6
Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis.外泌体源性烯醇化酶 1 调节整合素 α6β4 的表达,促进肝癌的生长和转移。
Cell Death Dis. 2020 Nov 12;11(11):972. doi: 10.1038/s41419-020-03179-1.
7
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.半乳糖凝集素-3 通过激活肝癌中的 β-连环蛋白信号促进肿瘤转移。
Br J Cancer. 2020 Nov;123(10):1521-1534. doi: 10.1038/s41416-020-1022-4. Epub 2020 Aug 17.
8
HIF-1α and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis.缺氧诱导的肝癌转移中,HIF-1α和HDAC1介导的FAM99A-miR92a信号调控发挥作用。
Signal Transduct Target Ther. 2020 Jul 7;5(1):118. doi: 10.1038/s41392-020-00223-6.
9
Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity.肝细胞癌的遗传学:探索分子多样性的方法
Hepatology. 2021 Jan;73 Suppl 1:14-26. doi: 10.1002/hep.31394. Epub 2020 Dec 8.
10
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.癌症中的上皮-间质转化:历史概述
Transl Oncol. 2020 Jun;13(6):100773. doi: 10.1016/j.tranon.2020.100773. Epub 2020 Apr 22.